Our clinical study
Our clinical study, Evaluation of Cultured Expanded Allogeneic, Cord-Derived Mesenchymal Stem Cells, Deployed via Intravenous Injection for Safety and Effect on Systemic Inflammation, is registered with the government of the Cayman Islands (Trial HPC/CTr/003).
Our stem cells
Our cells are ethically sourced from AATB certified, US-donated, full term human umbilical cords and processed in our award-winning partner medical laboratory located in the USA, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. The cells are tested for viability to ensure they meet minimum QA requirements multiple times before treatment.
Learn more
Revolutionizing
Mesenchymal Stem Cell Therapy
2009
2023
Evaluating efficacy of MSCs: Be part of our groundbreaking IRB-approved treatment protocol in the Cayman Islands using 300 million US manufactured GMP culture-expanded umbilical cord tissue derived mesenchymal stem cells.
Find out if you are a candidate
View our study protocol